nodes	percent_of_prediction	percent_of_DWPC	metapath
Mivacurium—CHRNA2—Mecamylamine—hypertension	0.331	0.549	CbGbCtD
Mivacurium—BCHE—Perindopril—hypertension	0.0959	0.159	CbGbCtD
Mivacurium—BCHE—Ramipril—hypertension	0.0795	0.132	CbGbCtD
Mivacurium—CHRM3—Nicardipine—hypertension	0.0535	0.0887	CbGbCtD
Mivacurium—CHRM2—Nicardipine—hypertension	0.0429	0.0712	CbGbCtD
Mivacurium—CHRND—heart—hypertension	0.00112	0.092	CbGeAlD
Mivacurium—CHRND—cardiovascular system—hypertension	0.00106	0.0868	CbGeAlD
Mivacurium—CHRNA2—heart—hypertension	0.000775	0.0637	CbGeAlD
Mivacurium—CHRNB1—heart—hypertension	0.000721	0.0593	CbGeAlD
Mivacurium—CHRNA1—endocrine gland—hypertension	0.000605	0.0497	CbGeAlD
Mivacurium—CHRNB1—medulla oblongata—hypertension	0.000582	0.0478	CbGeAlD
Mivacurium—CHRNB1—adrenal gland—hypertension	0.000538	0.0442	CbGeAlD
Mivacurium—CHRNA2—endocrine gland—hypertension	0.000502	0.0412	CbGeAlD
Mivacurium—BCHE—cardiac ventricle—hypertension	0.000468	0.0385	CbGeAlD
Mivacurium—CHRM2—heart—hypertension	0.000462	0.038	CbGeAlD
Mivacurium—CHRNA2—central nervous system—hypertension	0.000452	0.0372	CbGeAlD
Mivacurium—CHRM2—cardiovascular system—hypertension	0.000436	0.0358	CbGeAlD
Mivacurium—CHRM3—smooth muscle tissue—hypertension	0.000374	0.0307	CbGeAlD
Mivacurium—BCHE—brainstem—hypertension	0.000355	0.0292	CbGeAlD
Mivacurium—CHRM3—kidney—hypertension	0.000348	0.0286	CbGeAlD
Mivacurium—BCHE—nephron tubule—hypertension	0.000323	0.0265	CbGeAlD
Mivacurium—BCHE—heart—hypertension	0.000307	0.0253	CbGeAlD
Mivacurium—BCHE—smooth muscle tissue—hypertension	0.000305	0.0251	CbGeAlD
Mivacurium—CHRM2—endocrine gland—hypertension	0.000299	0.0246	CbGeAlD
Mivacurium—Dizziness—Guanfacine—hypertension	0.000292	0.00115	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Valsartan—hypertension	0.000291	0.00115	CcSEcCtD
Mivacurium—Hypotension—Doxazosin—hypertension	0.000291	0.00115	CcSEcCtD
Mivacurium—Dizziness—Nicardipine—hypertension	0.00029	0.00115	CcSEcCtD
Mivacurium—Angiopathy—Losartan—hypertension	0.00029	0.00115	CcSEcCtD
Mivacurium—BCHE—cardiovascular system—hypertension	0.00029	0.0238	CbGeAlD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Olmesartan—hypertension	0.00029	0.00115	CcSEcCtD
Mivacurium—Rash—Quinapril—hypertension	0.000289	0.00114	CcSEcCtD
Mivacurium—Dermatitis—Quinapril—hypertension	0.000289	0.00114	CcSEcCtD
Mivacurium—Erythema—Furosemide—hypertension	0.000289	0.00114	CcSEcCtD
Mivacurium—Dizziness—Metolazone—hypertension	0.000287	0.00114	CcSEcCtD
Mivacurium—Dizziness—Felodipine—hypertension	0.000287	0.00114	CcSEcCtD
Mivacurium—Hypotension—Fosinopril—hypertension	0.000287	0.00114	CcSEcCtD
Mivacurium—Dizziness—Spironolactone—hypertension	0.000286	0.00113	CcSEcCtD
Mivacurium—Arrhythmia—Losartan—hypertension	0.000286	0.00113	CcSEcCtD
Mivacurium—Erythema—Betaxolol—hypertension	0.000286	0.00113	CcSEcCtD
Mivacurium—Muscle spasms—Perindopril—hypertension	0.000285	0.00113	CcSEcCtD
Mivacurium—Hypotension—Eplerenone—hypertension	0.000285	0.00113	CcSEcCtD
Mivacurium—Rash—Benazepril—hypertension	0.000284	0.00112	CcSEcCtD
Mivacurium—Muscle spasms—Irbesartan—hypertension	0.000284	0.00112	CcSEcCtD
Mivacurium—Dermatitis—Benazepril—hypertension	0.000284	0.00112	CcSEcCtD
Mivacurium—Urticaria—Metoprolol—hypertension	0.000284	0.00112	CcSEcCtD
Mivacurium—Urticaria—Guanabenz—hypertension	0.000284	0.00112	CcSEcCtD
Mivacurium—Rash—Nadolol—hypertension	0.000283	0.00112	CcSEcCtD
Mivacurium—Hypotension—Nifedipine—hypertension	0.000283	0.00112	CcSEcCtD
Mivacurium—Dermatitis—Nadolol—hypertension	0.000283	0.00112	CcSEcCtD
Mivacurium—Muscle spasms—Hydrochlorothiazide—hypertension	0.000282	0.00112	CcSEcCtD
Mivacurium—Hypotension—Verapamil—hypertension	0.000282	0.00112	CcSEcCtD
Mivacurium—Anaphylactic shock—Valsartan—hypertension	0.000281	0.00111	CcSEcCtD
Mivacurium—Dizziness—Esmolol—hypertension	0.00028	0.00111	CcSEcCtD
Mivacurium—Anaphylactic shock—Olmesartan—hypertension	0.00028	0.00111	CcSEcCtD
Mivacurium—Rash—Isradipine—hypertension	0.000279	0.0011	CcSEcCtD
Mivacurium—Dermatitis—Isradipine—hypertension	0.000279	0.0011	CcSEcCtD
Mivacurium—Erythema—Losartan—hypertension	0.000278	0.0011	CcSEcCtD
Mivacurium—Rash—Guanfacine—hypertension	0.000278	0.0011	CcSEcCtD
Mivacurium—Dermatitis—Guanfacine—hypertension	0.000278	0.0011	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Clonidine—hypertension	0.000277	0.0011	CcSEcCtD
Mivacurium—Muscle spasms—Furosemide—hypertension	0.000277	0.0011	CcSEcCtD
Mivacurium—Rash—Nicardipine—hypertension	0.000277	0.0011	CcSEcCtD
Mivacurium—Dermatitis—Nicardipine—hypertension	0.000277	0.00109	CcSEcCtD
Mivacurium—Dizziness—Terazosin—hypertension	0.000277	0.00109	CcSEcCtD
Mivacurium—Muscle spasms—Betaxolol—hypertension	0.000275	0.00109	CcSEcCtD
Mivacurium—Rash—Felodipine—hypertension	0.000274	0.00108	CcSEcCtD
Mivacurium—Rash—Metolazone—hypertension	0.000274	0.00108	CcSEcCtD
Mivacurium—Dermatitis—Felodipine—hypertension	0.000274	0.00108	CcSEcCtD
Mivacurium—Dermatitis—Metolazone—hypertension	0.000274	0.00108	CcSEcCtD
Mivacurium—Bradycardia—Timolol—hypertension	0.000273	0.00108	CcSEcCtD
Mivacurium—Rash—Spironolactone—hypertension	0.000273	0.00108	CcSEcCtD
Mivacurium—Skin disorder—Valsartan—hypertension	0.000273	0.00108	CcSEcCtD
Mivacurium—Tachycardia—Olmesartan—hypertension	0.000273	0.00108	CcSEcCtD
Mivacurium—Dermatitis—Spironolactone—hypertension	0.000273	0.00108	CcSEcCtD
Mivacurium—Skin disorder—Olmesartan—hypertension	0.000272	0.00107	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Trandolapril—hypertension	0.000271	0.00107	CcSEcCtD
Mivacurium—Dizziness—Acebutolol—hypertension	0.00027	0.00107	CcSEcCtD
Mivacurium—CHRM2—central nervous system—hypertension	0.00027	0.0222	CbGeAlD
Mivacurium—Muscle spasms—Losartan—hypertension	0.000268	0.00106	CcSEcCtD
Mivacurium—Dizziness—Labetalol—hypertension	0.000267	0.00106	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Telmisartan—hypertension	0.000266	0.00105	CcSEcCtD
Mivacurium—Rash—Terazosin—hypertension	0.000264	0.00104	CcSEcCtD
Mivacurium—Dermatitis—Terazosin—hypertension	0.000264	0.00104	CcSEcCtD
Mivacurium—BCHE—cardiac atrium—hypertension	0.000263	0.0216	CbGeAlD
Mivacurium—Hypotension—Valsartan—hypertension	0.000263	0.00104	CcSEcCtD
Mivacurium—Tachycardia—Clonidine—hypertension	0.000261	0.00103	CcSEcCtD
Mivacurium—Hypotension—Olmesartan—hypertension	0.000261	0.00103	CcSEcCtD
Mivacurium—Urticaria—Propranolol—hypertension	0.000261	0.00103	CcSEcCtD
Mivacurium—Anaphylactic shock—Enalapril—hypertension	0.00026	0.00103	CcSEcCtD
Mivacurium—Skin disorder—Clonidine—hypertension	0.00026	0.00103	CcSEcCtD
Mivacurium—Dizziness—Eprosartan—hypertension	0.000259	0.00102	CcSEcCtD
Mivacurium—Rash—Acebutolol—hypertension	0.000257	0.00102	CcSEcCtD
Mivacurium—Dermatitis—Acebutolol—hypertension	0.000257	0.00102	CcSEcCtD
Mivacurium—Anaphylactic shock—Telmisartan—hypertension	0.000257	0.00101	CcSEcCtD
Mivacurium—Tachycardia—Trandolapril—hypertension	0.000255	0.00101	CcSEcCtD
Mivacurium—Rash—Labetalol—hypertension	0.000255	0.00101	CcSEcCtD
Mivacurium—Dermatitis—Labetalol—hypertension	0.000255	0.00101	CcSEcCtD
Mivacurium—Flushing—Ramipril—hypertension	0.000255	0.00101	CcSEcCtD
Mivacurium—Tachycardia—Enalapril—hypertension	0.000254	0.001	CcSEcCtD
Mivacurium—Skin disorder—Trandolapril—hypertension	0.000254	0.001	CcSEcCtD
Mivacurium—Bradycardia—Lisinopril—hypertension	0.000253	0.001	CcSEcCtD
Mivacurium—Urticaria—Indapamide—hypertension	0.000252	0.000998	CcSEcCtD
Mivacurium—Urticaria—Diltiazem—hypertension	0.000252	0.000998	CcSEcCtD
Mivacurium—Dizziness—Amlodipine—hypertension	0.000251	0.000994	CcSEcCtD
Mivacurium—Dizziness—Nisoldipine—hypertension	0.000251	0.000994	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Perindopril—hypertension	0.000251	0.000992	CcSEcCtD
Mivacurium—Tachycardia—Telmisartan—hypertension	0.00025	0.00099	CcSEcCtD
Mivacurium—Hypotension—Clonidine—hypertension	0.00025	0.00099	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—hypertension	0.00025	0.000989	CcSEcCtD
Mivacurium—Urticaria—Carvedilol—hypertension	0.00025	0.000988	CcSEcCtD
Mivacurium—Anaphylactic shock—Captopril—hypertension	0.00025	0.000987	CcSEcCtD
Mivacurium—Skin disorder—Telmisartan—hypertension	0.000249	0.000986	CcSEcCtD
Mivacurium—Cardiac disorder—Timolol—hypertension	0.000249	0.000984	CcSEcCtD
Mivacurium—BCHE—medulla oblongata—hypertension	0.000248	0.0204	CbGeAlD
Mivacurium—Immune system disorder—Ramipril—hypertension	0.000248	0.00098	CcSEcCtD
Mivacurium—Mediastinal disorder—Ramipril—hypertension	0.000247	0.000977	CcSEcCtD
Mivacurium—Urticaria—Doxazosin—hypertension	0.000247	0.000977	CcSEcCtD
Mivacurium—Rash—Eprosartan—hypertension	0.000247	0.000976	CcSEcCtD
Mivacurium—Dermatitis—Eprosartan—hypertension	0.000247	0.000975	CcSEcCtD
Mivacurium—Arrhythmia—Ramipril—hypertension	0.000245	0.000969	CcSEcCtD
Mivacurium—Hypotension—Trandolapril—hypertension	0.000244	0.000965	CcSEcCtD
Mivacurium—Urticaria—Fosinopril—hypertension	0.000244	0.000965	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Furosemide—hypertension	0.000244	0.000965	CcSEcCtD
Mivacurium—CHRM3—endocrine gland—hypertension	0.000244	0.02	CbGeAlD
Mivacurium—Tachycardia—Captopril—hypertension	0.000244	0.000963	CcSEcCtD
Mivacurium—Angiopathy—Timolol—hypertension	0.000243	0.000962	CcSEcCtD
Mivacurium—Hypotension—Enalapril—hypertension	0.000243	0.000961	CcSEcCtD
Mivacurium—Anaphylactic shock—Perindopril—hypertension	0.000242	0.000958	CcSEcCtD
Mivacurium—Immune system disorder—Timolol—hypertension	0.000242	0.000958	CcSEcCtD
Mivacurium—Mediastinal disorder—Timolol—hypertension	0.000242	0.000955	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—hypertension	0.000242	0.000955	CcSEcCtD
Mivacurium—Anaphylactic shock—Irbesartan—hypertension	0.000241	0.000955	CcSEcCtD
Mivacurium—Urticaria—Nifedipine—hypertension	0.000241	0.000952	CcSEcCtD
Mivacurium—Hypotension—Telmisartan—hypertension	0.00024	0.000948	CcSEcCtD
Mivacurium—Urticaria—Verapamil—hypertension	0.00024	0.000948	CcSEcCtD
Mivacurium—Rash—Nisoldipine—hypertension	0.00024	0.000948	CcSEcCtD
Mivacurium—Rash—Amlodipine—hypertension	0.00024	0.000948	CcSEcCtD
Mivacurium—Arrhythmia—Timolol—hypertension	0.00024	0.000947	CcSEcCtD
Mivacurium—Anaphylactic shock—Hydrochlorothiazide—hypertension	0.00024	0.000947	CcSEcCtD
Mivacurium—Dermatitis—Amlodipine—hypertension	0.000239	0.000947	CcSEcCtD
Mivacurium—Dermatitis—Nisoldipine—hypertension	0.000239	0.000947	CcSEcCtD
Mivacurium—Erythema—Ramipril—hypertension	0.000239	0.000944	CcSEcCtD
Mivacurium—Tachycardia—Perindopril—hypertension	0.000236	0.000935	CcSEcCtD
Mivacurium—Dizziness—Metoprolol—hypertension	0.000236	0.000934	CcSEcCtD
Mivacurium—Dizziness—Guanabenz—hypertension	0.000236	0.000934	CcSEcCtD
Mivacurium—Tachycardia—Irbesartan—hypertension	0.000236	0.000932	CcSEcCtD
Mivacurium—Anaphylactic shock—Furosemide—hypertension	0.000236	0.000931	CcSEcCtD
Mivacurium—Skin disorder—Perindopril—hypertension	0.000235	0.00093	CcSEcCtD
Mivacurium—Skin disorder—Irbesartan—hypertension	0.000235	0.000927	CcSEcCtD
Mivacurium—Tachycardia—Hydrochlorothiazide—hypertension	0.000234	0.000924	CcSEcCtD
Mivacurium—Erythema—Timolol—hypertension	0.000233	0.000923	CcSEcCtD
Mivacurium—Hypotension—Captopril—hypertension	0.000233	0.000922	CcSEcCtD
Mivacurium—Flushing—Lisinopril—hypertension	0.000231	0.000913	CcSEcCtD
Mivacurium—Muscle spasms—Ramipril—hypertension	0.00023	0.000908	CcSEcCtD
Mivacurium—BCHE—adrenal gland—hypertension	0.000229	0.0189	CbGeAlD
Mivacurium—Skin disorder—Furosemide—hypertension	0.000229	0.000905	CcSEcCtD
Mivacurium—Tachycardia—Betaxolol—hypertension	0.000228	0.0009	CcSEcCtD
Mivacurium—Anaphylactic shock—Losartan—hypertension	0.000227	0.000899	CcSEcCtD
Mivacurium—Skin disorder—Betaxolol—hypertension	0.000227	0.000896	CcSEcCtD
Mivacurium—Hypotension—Perindopril—hypertension	0.000226	0.000895	CcSEcCtD
Mivacurium—Angiopathy—Lisinopril—hypertension	0.000226	0.000892	CcSEcCtD
Mivacurium—Hypotension—Irbesartan—hypertension	0.000226	0.000892	CcSEcCtD
Mivacurium—Rash—Guanabenz—hypertension	0.000225	0.000891	CcSEcCtD
Mivacurium—Rash—Metoprolol—hypertension	0.000225	0.000891	CcSEcCtD
Mivacurium—Dermatitis—Guanabenz—hypertension	0.000225	0.00089	CcSEcCtD
Mivacurium—Dermatitis—Metoprolol—hypertension	0.000225	0.00089	CcSEcCtD
Mivacurium—Mediastinal disorder—Lisinopril—hypertension	0.000224	0.000886	CcSEcCtD
Mivacurium—Hypotension—Hydrochlorothiazide—hypertension	0.000224	0.000885	CcSEcCtD
Mivacurium—Urticaria—Valsartan—hypertension	0.000223	0.000883	CcSEcCtD
Mivacurium—Arrhythmia—Lisinopril—hypertension	0.000222	0.000879	CcSEcCtD
Mivacurium—Urticaria—Olmesartan—hypertension	0.000222	0.000878	CcSEcCtD
Mivacurium—Tachycardia—Losartan—hypertension	0.000222	0.000877	CcSEcCtD
Mivacurium—Hypotension—Furosemide—hypertension	0.00022	0.00087	CcSEcCtD
Mivacurium—CHRM3—central nervous system—hypertension	0.00022	0.018	CbGeAlD
Mivacurium—Hypotension—Betaxolol—hypertension	0.000218	0.000862	CcSEcCtD
Mivacurium—Dizziness—Propranolol—hypertension	0.000217	0.000858	CcSEcCtD
Mivacurium—Erythema—Lisinopril—hypertension	0.000217	0.000856	CcSEcCtD
Mivacurium—Urticaria—Clonidine—hypertension	0.000213	0.000841	CcSEcCtD
Mivacurium—Hypotension—Losartan—hypertension	0.000212	0.00084	CcSEcCtD
Mivacurium—Dizziness—Indapamide—hypertension	0.00021	0.00083	CcSEcCtD
Mivacurium—Dizziness—Diltiazem—hypertension	0.00021	0.00083	CcSEcCtD
Mivacurium—Muscle spasms—Lisinopril—hypertension	0.000208	0.000823	CcSEcCtD
Mivacurium—Dizziness—Carvedilol—hypertension	0.000208	0.000822	CcSEcCtD
Mivacurium—Urticaria—Trandolapril—hypertension	0.000208	0.000821	CcSEcCtD
Mivacurium—Rash—Propranolol—hypertension	0.000207	0.000818	CcSEcCtD
Mivacurium—Urticaria—Enalapril—hypertension	0.000207	0.000817	CcSEcCtD
Mivacurium—Dermatitis—Propranolol—hypertension	0.000207	0.000817	CcSEcCtD
Mivacurium—Dizziness—Doxazosin—hypertension	0.000206	0.000813	CcSEcCtD
Mivacurium—Urticaria—Telmisartan—hypertension	0.000204	0.000806	CcSEcCtD
Mivacurium—Dizziness—Fosinopril—hypertension	0.000203	0.000803	CcSEcCtD
Mivacurium—Dizziness—Eplerenone—hypertension	0.000202	0.000798	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Ramipril—hypertension	0.000202	0.000798	CcSEcCtD
Mivacurium—Dizziness—Nifedipine—hypertension	0.0002	0.000793	CcSEcCtD
Mivacurium—Rash—Indapamide—hypertension	0.0002	0.000792	CcSEcCtD
Mivacurium—Rash—Diltiazem—hypertension	0.0002	0.000792	CcSEcCtD
Mivacurium—Dermatitis—Diltiazem—hypertension	0.0002	0.000791	CcSEcCtD
Mivacurium—Dermatitis—Indapamide—hypertension	0.0002	0.000791	CcSEcCtD
Mivacurium—Dizziness—Verapamil—hypertension	0.0002	0.000789	CcSEcCtD
Mivacurium—BCHE—endocrine gland—hypertension	0.000199	0.0163	CbGeAlD
Mivacurium—Rash—Carvedilol—hypertension	0.000198	0.000784	CcSEcCtD
Mivacurium—Dermatitis—Carvedilol—hypertension	0.000198	0.000783	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	0.000197	0.00078	CcSEcCtD
Mivacurium—Rash—Doxazosin—hypertension	0.000196	0.000775	CcSEcCtD
Mivacurium—Dermatitis—Doxazosin—hypertension	0.000196	0.000775	CcSEcCtD
Mivacurium—Anaphylactic shock—Ramipril—hypertension	0.000195	0.00077	CcSEcCtD
Mivacurium—Rash—Fosinopril—hypertension	0.000194	0.000766	CcSEcCtD
Mivacurium—Dermatitis—Fosinopril—hypertension	0.000194	0.000765	CcSEcCtD
Mivacurium—Rash—Eplerenone—hypertension	0.000193	0.000761	CcSEcCtD
Mivacurium—Urticaria—Perindopril—hypertension	0.000192	0.000761	CcSEcCtD
Mivacurium—Dermatitis—Eplerenone—hypertension	0.000192	0.000761	CcSEcCtD
Mivacurium—Urticaria—Irbesartan—hypertension	0.000192	0.000758	CcSEcCtD
Mivacurium—Rash—Nifedipine—hypertension	0.000191	0.000756	CcSEcCtD
Mivacurium—Dermatitis—Nifedipine—hypertension	0.000191	0.000755	CcSEcCtD
Mivacurium—Anaphylactic shock—Timolol—hypertension	0.00019	0.000753	CcSEcCtD
Mivacurium—Rash—Verapamil—hypertension	0.00019	0.000752	CcSEcCtD
Mivacurium—Urticaria—Hydrochlorothiazide—hypertension	0.00019	0.000752	CcSEcCtD
Mivacurium—Tachycardia—Ramipril—hypertension	0.00019	0.000752	CcSEcCtD
Mivacurium—Dermatitis—Verapamil—hypertension	0.00019	0.000752	CcSEcCtD
Mivacurium—Skin disorder—Ramipril—hypertension	0.000189	0.000748	CcSEcCtD
Mivacurium—Urticaria—Furosemide—hypertension	0.000187	0.00074	CcSEcCtD
Mivacurium—Dizziness—Valsartan—hypertension	0.000186	0.000735	CcSEcCtD
Mivacurium—Urticaria—Betaxolol—hypertension	0.000185	0.000732	CcSEcCtD
Mivacurium—Skin disorder—Timolol—hypertension	0.000185	0.000732	CcSEcCtD
Mivacurium—Dizziness—Olmesartan—hypertension	0.000185	0.000731	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	0.000183	0.000724	CcSEcCtD
Mivacurium—Hypotension—Ramipril—hypertension	0.000182	0.00072	CcSEcCtD
Mivacurium—Urticaria—Losartan—hypertension	0.000181	0.000714	CcSEcCtD
Mivacurium—BCHE—central nervous system—hypertension	0.000179	0.0147	CbGeAlD
Mivacurium—Hypotension—Timolol—hypertension	0.000178	0.000704	CcSEcCtD
Mivacurium—Rash—Valsartan—hypertension	0.000177	0.0007	CcSEcCtD
Mivacurium—Dizziness—Clonidine—hypertension	0.000177	0.0007	CcSEcCtD
Mivacurium—Dermatitis—Valsartan—hypertension	0.000177	0.0007	CcSEcCtD
Mivacurium—Anaphylactic shock—Lisinopril—hypertension	0.000177	0.000699	CcSEcCtD
Mivacurium—Rash—Olmesartan—hypertension	0.000176	0.000697	CcSEcCtD
Mivacurium—Dermatitis—Olmesartan—hypertension	0.000176	0.000696	CcSEcCtD
Mivacurium—Dizziness—Trandolapril—hypertension	0.000173	0.000683	CcSEcCtD
Mivacurium—Tachycardia—Lisinopril—hypertension	0.000172	0.000682	CcSEcCtD
Mivacurium—Dizziness—Enalapril—hypertension	0.000172	0.00068	CcSEcCtD
Mivacurium—Skin disorder—Lisinopril—hypertension	0.000172	0.000679	CcSEcCtD
Mivacurium—Dizziness—Telmisartan—hypertension	0.00017	0.000671	CcSEcCtD
Mivacurium—Rash—Clonidine—hypertension	0.000169	0.000668	CcSEcCtD
Mivacurium—Dermatitis—Clonidine—hypertension	0.000169	0.000667	CcSEcCtD
Mivacurium—Hypotension—Lisinopril—hypertension	0.000165	0.000653	CcSEcCtD
Mivacurium—Dizziness—Captopril—hypertension	0.000165	0.000652	CcSEcCtD
Mivacurium—Rash—Trandolapril—hypertension	0.000165	0.000651	CcSEcCtD
Mivacurium—Dermatitis—Trandolapril—hypertension	0.000165	0.000651	CcSEcCtD
Mivacurium—Rash—Enalapril—hypertension	0.000164	0.000649	CcSEcCtD
Mivacurium—Dermatitis—Enalapril—hypertension	0.000164	0.000648	CcSEcCtD
Mivacurium—Rash—Telmisartan—hypertension	0.000162	0.00064	CcSEcCtD
Mivacurium—Dermatitis—Telmisartan—hypertension	0.000162	0.000639	CcSEcCtD
Mivacurium—Dizziness—Perindopril—hypertension	0.00016	0.000633	CcSEcCtD
Mivacurium—Dizziness—Irbesartan—hypertension	0.00016	0.000631	CcSEcCtD
Mivacurium—Dizziness—Hydrochlorothiazide—hypertension	0.000158	0.000626	CcSEcCtD
Mivacurium—Rash—Captopril—hypertension	0.000157	0.000622	CcSEcCtD
Mivacurium—Dermatitis—Captopril—hypertension	0.000157	0.000622	CcSEcCtD
Mivacurium—Dizziness—Furosemide—hypertension	0.000156	0.000616	CcSEcCtD
Mivacurium—Urticaria—Ramipril—hypertension	0.000155	0.000612	CcSEcCtD
Mivacurium—Dizziness—Betaxolol—hypertension	0.000154	0.00061	CcSEcCtD
Mivacurium—Rash—Perindopril—hypertension	0.000153	0.000604	CcSEcCtD
Mivacurium—Dermatitis—Perindopril—hypertension	0.000153	0.000603	CcSEcCtD
Mivacurium—Rash—Irbesartan—hypertension	0.000152	0.000602	CcSEcCtD
Mivacurium—Dermatitis—Irbesartan—hypertension	0.000152	0.000601	CcSEcCtD
Mivacurium—Urticaria—Timolol—hypertension	0.000151	0.000598	CcSEcCtD
Mivacurium—Rash—Hydrochlorothiazide—hypertension	0.000151	0.000597	CcSEcCtD
Mivacurium—Dermatitis—Hydrochlorothiazide—hypertension	0.000151	0.000597	CcSEcCtD
Mivacurium—Dizziness—Losartan—hypertension	0.00015	0.000594	CcSEcCtD
Mivacurium—Rash—Furosemide—hypertension	0.000149	0.000587	CcSEcCtD
Mivacurium—Dermatitis—Furosemide—hypertension	0.000148	0.000587	CcSEcCtD
Mivacurium—Rash—Betaxolol—hypertension	0.000147	0.000581	CcSEcCtD
Mivacurium—Dermatitis—Betaxolol—hypertension	0.000147	0.000581	CcSEcCtD
Mivacurium—Rash—Losartan—hypertension	0.000143	0.000567	CcSEcCtD
Mivacurium—Dermatitis—Losartan—hypertension	0.000143	0.000566	CcSEcCtD
Mivacurium—Urticaria—Lisinopril—hypertension	0.00014	0.000555	CcSEcCtD
Mivacurium—Dizziness—Ramipril—hypertension	0.000129	0.000509	CcSEcCtD
Mivacurium—Dizziness—Timolol—hypertension	0.000126	0.000498	CcSEcCtD
Mivacurium—Rash—Ramipril—hypertension	0.000123	0.000486	CcSEcCtD
Mivacurium—Dermatitis—Ramipril—hypertension	0.000123	0.000485	CcSEcCtD
Mivacurium—Rash—Timolol—hypertension	0.00012	0.000475	CcSEcCtD
Mivacurium—Dermatitis—Timolol—hypertension	0.00012	0.000474	CcSEcCtD
Mivacurium—Dizziness—Lisinopril—hypertension	0.000117	0.000462	CcSEcCtD
Mivacurium—Rash—Lisinopril—hypertension	0.000111	0.000441	CcSEcCtD
Mivacurium—Dermatitis—Lisinopril—hypertension	0.000111	0.00044	CcSEcCtD
Mivacurium—CHRM3—Signaling by GPCR—F2—hypertension	1.02e-05	7.79e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PRKCB—hypertension	1.02e-05	7.79e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—COMT—hypertension	1.02e-05	7.75e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—BDKRB2—hypertension	1.02e-05	7.75e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—AGT—hypertension	1.02e-05	7.74e-05	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—POMC—hypertension	1.02e-05	7.74e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ADRBK1—hypertension	1.02e-05	7.74e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—F2—hypertension	1.02e-05	7.71e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PRKCB—hypertension	1.02e-05	7.71e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CNR1—hypertension	1.01e-05	7.68e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ADRBK1—hypertension	1.01e-05	7.66e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GNB3—hypertension	1.01e-05	7.64e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PPARGC1A—hypertension	1.01e-05	7.64e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—CALM1—hypertension	1e-05	7.61e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—HMOX1—hypertension	1e-05	7.61e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CNR1—hypertension	1e-05	7.6e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CALM2—hypertension	1e-05	7.6e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—APOE—hypertension	9.99e-06	7.59e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CALM2—hypertension	9.9e-06	7.52e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—CAV1—hypertension	9.89e-06	7.52e-05	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—AKT2—hypertension	9.88e-06	7.51e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CAT—hypertension	9.88e-06	7.51e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—APOA1—hypertension	9.87e-06	7.5e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HTR7—hypertension	9.86e-06	7.49e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—DRD2—hypertension	9.86e-06	7.49e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GNAS—hypertension	9.8e-06	7.44e-05	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—AKT2—hypertension	9.79e-06	7.44e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HTR7—hypertension	9.76e-06	7.42e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—DRD2—hypertension	9.76e-06	7.42e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GCG—hypertension	9.76e-06	7.42e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PTPN1—hypertension	9.76e-06	7.42e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GCG—hypertension	9.67e-06	7.34e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PTPN1—hypertension	9.67e-06	7.34e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—APOB—hypertension	9.59e-06	7.29e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—KL—hypertension	9.57e-06	7.27e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NOTCH2—hypertension	9.57e-06	7.27e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—KL—hypertension	9.48e-06	7.2e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NOTCH2—hypertension	9.48e-06	7.2e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NGFR—hypertension	9.4e-06	7.14e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ITGAV—hypertension	9.4e-06	7.14e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—KNG1—hypertension	9.37e-06	7.12e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—POMC—hypertension	9.34e-06	7.09e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GSTM1—hypertension	9.33e-06	7.09e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—AGTR1—hypertension	9.31e-06	7.08e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PRL—hypertension	9.31e-06	7.08e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ITGAV—hypertension	9.3e-06	7.07e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NGFR—hypertension	9.3e-06	7.07e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—KNG1—hypertension	9.28e-06	7.05e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—POMC—hypertension	9.25e-06	7.03e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—AGTR1—hypertension	9.22e-06	7.01e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PRL—hypertension	9.22e-06	7.01e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—STK11—hypertension	9.18e-06	6.97e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HDAC1—hypertension	9.18e-06	6.97e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—LPL—hypertension	9.16e-06	6.96e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CCL2—hypertension	9.14e-06	6.94e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CXCL10—hypertension	9.1e-06	6.91e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—STK11—hypertension	9.09e-06	6.91e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HDAC1—hypertension	9.09e-06	6.91e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PLG—hypertension	9.07e-06	6.9e-05	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—RHOA—hypertension	9.06e-06	6.88e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CCL2—hypertension	9.05e-06	6.87e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CXCL10—hypertension	9.01e-06	6.85e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PLG—hypertension	8.99e-06	6.83e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—AKT2—hypertension	8.97e-06	6.82e-05	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—RHOA—hypertension	8.97e-06	6.82e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ADCY5—hypertension	8.97e-06	6.81e-05	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PIK3R1—hypertension	8.97e-06	6.81e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GPX1—hypertension	8.94e-06	6.79e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—AKT2—hypertension	8.89e-06	6.75e-05	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PIK3R1—hypertension	8.88e-06	6.75e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PRKCA—hypertension	8.85e-06	6.72e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CYP1A1—hypertension	8.85e-06	6.72e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ADRB2—hypertension	8.83e-06	6.71e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ADRB2—hypertension	8.75e-06	6.65e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PRKCE—hypertension	8.72e-06	6.63e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CD36—hypertension	8.7e-06	6.61e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PPARG—hypertension	8.7e-06	6.61e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PRKCE—hypertension	8.64e-06	6.56e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—VAV3—hypertension	8.61e-06	6.55e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PDGFA—hypertension	8.61e-06	6.55e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—POMC—hypertension	8.58e-06	6.52e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PDGFA—hypertension	8.53e-06	6.48e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—VAV3—hypertension	8.53e-06	6.48e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—INS—hypertension	8.53e-06	6.48e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TGFBR2—hypertension	8.49e-06	6.45e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GNB3—hypertension	8.41e-06	6.39e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TGFBR2—hypertension	8.41e-06	6.39e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GNB3—hypertension	8.33e-06	6.33e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—AVP—hypertension	8.3e-06	6.31e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—MTHFR—hypertension	8.25e-06	6.27e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—RHOA—hypertension	8.23e-06	6.25e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—AVP—hypertension	8.22e-06	6.25e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GNAS—hypertension	8.19e-06	6.22e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—RHOA—hypertension	8.15e-06	6.19e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PIK3R1—hypertension	8.14e-06	6.19e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GNAS—hypertension	8.11e-06	6.16e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PPARA—hypertension	8.09e-06	6.15e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PIK3R1—hypertension	8.06e-06	6.13e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APOB—hypertension	8.02e-06	6.1e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PTK2—hypertension	7.99e-06	6.07e-05	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—CXCL8—hypertension	7.95e-06	6.04e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APOB—hypertension	7.94e-06	6.04e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PTK2—hypertension	7.91e-06	6.01e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—EDN1—hypertension	7.89e-06	6e-05	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—CXCL8—hypertension	7.88e-06	5.98e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—AGT—hypertension	7.84e-06	5.95e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CCL5—hypertension	7.83e-06	5.95e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—ALB—hypertension	7.82e-06	5.94e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—EDN1—hypertension	7.82e-06	5.94e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CCL5—hypertension	7.76e-06	5.89e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CALM1—hypertension	7.71e-06	5.85e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—APOE—hypertension	7.68e-06	5.83e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—LPL—hypertension	7.66e-06	5.82e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CAV1—hypertension	7.61e-06	5.78e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—H2AFX—hypertension	7.6e-06	5.78e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—RPS6KB1—hypertension	7.59e-06	5.77e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PDGFRB—hypertension	7.59e-06	5.77e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—APOA1—hypertension	7.59e-06	5.77e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—LPL—hypertension	7.59e-06	5.76e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—H2AFX—hypertension	7.53e-06	5.72e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PDGFRB—hypertension	7.52e-06	5.71e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—RPS6KB1—hypertension	7.52e-06	5.71e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ADCY5—hypertension	7.5e-06	5.7e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PIK3R1—hypertension	7.48e-06	5.68e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—NOS3—hypertension	7.48e-06	5.68e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PRKCG—hypertension	7.45e-06	5.66e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ADCY5—hypertension	7.43e-06	5.64e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PRKCA—hypertension	7.4e-06	5.62e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ITGB3—hypertension	7.4e-06	5.62e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PRKCG—hypertension	7.38e-06	5.6e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—YWHAZ—hypertension	7.34e-06	5.57e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ITGB3—hypertension	7.33e-06	5.57e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PRKCA—hypertension	7.33e-06	5.57e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—YWHAZ—hypertension	7.27e-06	5.52e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SPP1—hypertension	7.25e-06	5.51e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NGF—hypertension	7.25e-06	5.51e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CXCL8—hypertension	7.22e-06	5.49e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SPP1—hypertension	7.18e-06	5.46e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NGF—hypertension	7.18e-06	5.46e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CXCL8—hypertension	7.15e-06	5.43e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CCR5—hypertension	7.06e-06	5.36e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PRKCD—hypertension	7.06e-06	5.36e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PRKCD—hypertension	6.99e-06	5.31e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CCR5—hypertension	6.99e-06	5.31e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HTR2A—hypertension	6.91e-06	5.25e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—C3—hypertension	6.9e-06	5.24e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PTGS2—hypertension	6.84e-06	5.2e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HTR2A—hypertension	6.84e-06	5.2e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—C3—hypertension	6.83e-06	5.19e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PDGFB—hypertension	6.71e-06	5.1e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PPARG—hypertension	6.69e-06	5.08e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—FGFR1—hypertension	6.68e-06	5.07e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PDGFB—hypertension	6.65e-06	5.05e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—FGFR1—hypertension	6.61e-06	5.02e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—POMC—hypertension	6.6e-06	5.01e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HIF1A—hypertension	6.58e-06	5e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—INS—hypertension	6.56e-06	4.98e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—AGT—hypertension	6.55e-06	4.98e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HIF1A—hypertension	6.51e-06	4.95e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—AGT—hypertension	6.49e-06	4.93e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CALM1—hypertension	6.44e-06	4.9e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—LEP—hypertension	6.42e-06	4.88e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APOE—hypertension	6.42e-06	4.88e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CALM1—hypertension	6.38e-06	4.85e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CAV1—hypertension	6.36e-06	4.83e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—LEP—hypertension	6.36e-06	4.83e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APOE—hypertension	6.36e-06	4.83e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APOA1—hypertension	6.35e-06	4.82e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CAV1—hypertension	6.3e-06	4.79e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—KDR—hypertension	6.29e-06	4.78e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APOA1—hypertension	6.29e-06	4.78e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—KDR—hypertension	6.23e-06	4.73e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—FN1—hypertension	6.05e-06	4.6e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—F2—hypertension	6.05e-06	4.6e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PRKCB—hypertension	6.05e-06	4.6e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ALB—hypertension	6.01e-06	4.57e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—FN1—hypertension	6e-06	4.56e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PRKCB—hypertension	6e-06	4.56e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—F2—hypertension	6e-06	4.56e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PTEN—hypertension	5.97e-06	4.53e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NOTCH1—hypertension	5.93e-06	4.5e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NOTCH1—hypertension	5.87e-06	4.46e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PIK3R1—hypertension	5.75e-06	4.37e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—NOS3—hypertension	5.75e-06	4.37e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—EP300—hypertension	5.69e-06	4.32e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—POMC—hypertension	5.52e-06	4.19e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—INS—hypertension	5.49e-06	4.17e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—POMC—hypertension	5.46e-06	4.15e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—INS—hypertension	5.43e-06	4.13e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CCL2—hypertension	5.4e-06	4.1e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CCL2—hypertension	5.34e-06	4.06e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IGF1—hypertension	5.31e-06	4.03e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—AKT2—hypertension	5.3e-06	4.03e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—EGFR—hypertension	5.28e-06	4.01e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PTGS2—hypertension	5.26e-06	4e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IGF1—hypertension	5.25e-06	3.99e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—AKT2—hypertension	5.25e-06	3.99e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—EGFR—hypertension	5.23e-06	3.97e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SERPINE1—hypertension	5.04e-06	3.83e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SERPINE1—hypertension	4.99e-06	3.79e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—FGF2—hypertension	4.88e-06	3.71e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—RHOA—hypertension	4.86e-06	3.69e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—FGF2—hypertension	4.83e-06	3.67e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—RHOA—hypertension	4.81e-06	3.66e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PIK3R1—hypertension	4.81e-06	3.65e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NOS3—hypertension	4.81e-06	3.65e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NOS3—hypertension	4.76e-06	3.62e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PIK3R1—hypertension	4.76e-06	3.62e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PTEN—hypertension	4.59e-06	3.49e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—RELA—hypertension	4.53e-06	3.44e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—RELA—hypertension	4.48e-06	3.41e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MTOR—hypertension	4.44e-06	3.37e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MTOR—hypertension	4.4e-06	3.34e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—EP300—hypertension	4.38e-06	3.32e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CXCL8—hypertension	4.27e-06	3.24e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CXCL8—hypertension	4.23e-06	3.21e-05	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—AKT1—hypertension	4.12e-06	3.13e-05	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—AKT1—hypertension	4.08e-06	3.1e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—IL6—hypertension	4.06e-06	3.08e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—IL6—hypertension	4.02e-06	3.05e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MMP9—hypertension	3.86e-06	2.93e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CDKN1A—hypertension	3.85e-06	2.92e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PTEN—hypertension	3.84e-06	2.92e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MMP9—hypertension	3.82e-06	2.9e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CDKN1A—hypertension	3.81e-06	2.89e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PTEN—hypertension	3.8e-06	2.89e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MAPK8—hypertension	3.75e-06	2.85e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—AKT1—hypertension	3.74e-06	2.84e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MAPK8—hypertension	3.72e-06	2.82e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—AKT1—hypertension	3.71e-06	2.82e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—EP300—hypertension	3.66e-06	2.78e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—EP300—hypertension	3.62e-06	2.75e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SRC—hypertension	3.56e-06	2.7e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SRC—hypertension	3.52e-06	2.68e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—VEGFA—hypertension	3.47e-06	2.63e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—AKT1—hypertension	3.44e-06	2.61e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—VEGFA—hypertension	3.43e-06	2.61e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MYC—hypertension	3.19e-06	2.42e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TGFB1—hypertension	3.18e-06	2.42e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MYC—hypertension	3.16e-06	2.4e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TGFB1—hypertension	3.15e-06	2.39e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—EGFR—hypertension	3.12e-06	2.37e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—EGFR—hypertension	3.09e-06	2.35e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—AKT1—hypertension	2.64e-06	2.01e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TP53—hypertension	2.62e-06	1.99e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TP53—hypertension	2.59e-06	1.97e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IL6—hypertension	2.4e-06	1.82e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IL6—hypertension	2.37e-06	1.8e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—AKT1—hypertension	2.21e-06	1.68e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—AKT1—hypertension	2.19e-06	1.66e-05	CbGpPWpGaD
